Trial Details

RECRUITING
Basic Information
Clinical ID c1873
Identifier NCT05912387
Trial Title Statin Therapy in Primary Sclerosing Cholangitis (PSC): a Multi-omics Study
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Primary Sclerosing Cholangitis; Inflammatory Bowel Diseases
Interventions DRUG: Rosuvastatin
Participant Information
Sponsor Stanford University
City Stanford
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type INTERVENTIONAL
Phase EARLY_PHASE1
Time Information
Start Date 2023-05-31
Primary Completion Date 2025-05-31
Completion Date 2025-12-31